Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Kim-Schulze
S. Kim-Schulze
Columbia University Medical Center
Medicine
Pathology
Interleukin 2
Renal cell carcinoma
Immune system
5
Papers
314
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I clinical trial of MVA expressing 5T4 and high-dose interleukin-2 (IL-2) for metastatic renal cell carcinoma
2016
Journal of Clinical Oncology
Howard L. Kaufman
Gail DeRaffele
Josephine Mitcham
Dorota Moroziewicz
S. Kim-Schulze
Christian Petrulio
Richard Harrop
Stuart Naylor
Show All
Source
Cite
Save
Citations (4)
Evaluation of poxviruses targeting the tumor microenvironment for cancer therapy.
2010
Journal of Clinical Oncology
Dae Won Kim
S. Kim-Schulze
Gail DeRaffele
Jeffrey Schlom
Howard L. Kaufman
Show All
Source
Cite
Save
Citations (0)
Correlation of effector and regulatory T cell responses with clinical outcome in metastatic renal cell carcinoma patients treated with MVA-5T4 vaccine and high-dose interleukin-2
2008
Journal of Clinical Oncology
Howard L. Kaufman
S. Kim-Schulze
Dae Won Kim
Dorota Moroziewicz
Gail DeRaffele
Josephine Mitcham
William Shingler
Richard Harrop
Stuart Naylor
Show All
Source
Cite
Save
Citations (1)
Advances in Immune Monitoring Strategies for Cancer Vaccines and Immunotherapy
2007
S. Kim-Schulze
Moshe Ornstein
Howard L Kaufman
Show All
Source
Cite
Save
Citations (0)
Characterization of CD4+CD25+ Regulatory T Cells in Patients Treated With High-Dose Interleukin-2 for Metastatic Melanoma or Renal Cell Carcinoma
2006
Journal of Clinical Oncology
Giovanni C. Cesana
Gail DeRaffele
Seth Cohen
Dorota Moroziewicz
Josephine Mitcham
John Stoutenburg
Ken Cheung
Charles Hesdorffer
S. Kim-Schulze
Howard L Kaufman
Show All
Source
Cite
Save
Citations (309)
1
map